Quantitative Radiology Solutions (QRS) has raised an additional $230,000 from Phase 1 Ventures to support 510(k) clearance of its Automatic Anatomy Recognition (AAR) software for radiation treatment planning.  The company is leveraging an STTR grant from the National Cancer Institute to complete its product development and conduct a clinical evaluation at 4 academic medical centers. … Read More


QRS is proud to annouce Steve Owens has joined our team as Chief Technology Officer. Mr. Owens is an experienced leader of Innovation Centers focused on research, product development, software engineering, and IT operations in the pharmaceutical research and medical device industries. He has a record of accomplishment of leading and developing people and organizations transform… Read More


ASTRO 2017

QRS presented STTR Phase I results in 2 posters at ASTRO 2017: “Auto-contouring for Radiation Therapy: Challenges in Standardizing Object Definitions, Ground Truth Delineations, Object Quality and Image Quality” and  “A High-Performance Software System for Auto Contouring Anatomy in Adaptive Radiation Therapy.” ASTRO is the premier radiation oncology society in the world, with more than… Read More


QRS CEO Joe Camaratta presented at Life Sciences Future. Life Sciences Future is a conference bringing together Pennsylvania’s diverse life sciences industry – pharma, biotech, medical device and diagnostics, healthcare IT, contract research organizations, academic research institutions, and the investment community. Learn More… Read More


QRS CEO Joe Camaratta presented the company’s fund-raising opportunity at Mid-Atlantic Diamond Ventures Fall Forum. Mid-Atlantic Diamond Ventures (MADV) is an independent organization that assists emerging, technology-based companies in their effort to build sustainable businesses by better positioning their firms for funding while increasing value at an early and crucial stage. To date, 386 Mid-Atlantic companies have… Read More


QRS presented its first poster at the American Association of Physics on Aug. 2, 2017. The poster addressed evaluation of segmentation methods as a function of the quality of input images. Learn More… Read More


QRS was selected as one of the Top 30 Life Sciences Startups in the RESI Innovation Challenge. From a pool of approximately 100 applicants, the LSN Scientific Review Team has selected QRS among a diverse group of life science startups: three healthcare IT, three diagnostic, thirteen therapeutic, and eleven medical device companies.  QRS will showcase in… Read More


QRS will be presenting its findings on “Evaluation of segmentation methods as a function of the quality of input images” at the American Association of Physicists in Medicine (AAPM) conference in Denver starting 7/30. Additionally, the company will “A high-performance software system for auto contouring head and neck anatomy in adaptive radiation therapy” and “Knowledge-based… Read More